India?s first indigenous drug against malaria, Synriam, has been launched with great fanfare by Ranbaxy. FE examines the economics, therapeutic…
If you want to see one place where the business school philosophy of management diversity is turned on its head,…
India could be hosting 24 lakh medical tourists by 2020, almost four times the number it catered to in 2010.
Top patent-seekers from US, Japan and China ? who file the maximum patent applications ? hail from IT, telecom and…
With over 55% of Indian women and 70% of children suffering from anaemia, a double fortified salt with iodine and…
Cos making most of technology to deliver basic services at doorsteps.
The $11-billion plus Dutch multinational DSM with core interest in life sciences and material science has set a target to…
Medical technology companies, particularly those that market medical devices in the country, are in a fix over how to train…
The Indian patent office?s ruling on the grant of the first compulsory licence to the generic drug firm Natco on…
As the country embarks on the road to universal health coverage with the Prime Minister?s Office indicating an increase in…
Five of India?s top 10 pharma firms collectively raked in their best quarterly revenues in the US in October-December…
Ranbaxy Labs has managed to grab the largest market share of cholesterol-lowering drug Lipitor…
Ranbaxy Labs has handed over the marketing and distribution of its drug portfolio in the $11-billion Mexican market to parent…
The food business operators in the country may be asked by the government to put in place a mobile-based technology…
Cadila Pharma, promoted by Rajiv Modi, is in the final stages of floating an equal partnership joint venture with Swedish…
The domestic pharma industry has contested claims from certain quarters that using the prices of the three top-selling drug brands…
Pfizer India, the local arm of one of the largest global pharma companies, has begun…
In the R60,000-crore domestic drug market, Sun Pharmaceutical is on the brink of crossing GlaxoSmithKline to become the third largest…
